-
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Average Rating of "Buy" by Analysts
Source: Buzz FX / 28 Nov 2024 03:51:10 America/New_York
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Average Rating of "Buy" by Analysts Written by MarketBeat November 28, 2024 Share Link copied to clipboard. Shares of Day One Biopharmaceuticals, Inc.
Read more...